These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2886178)

  • 1. Sulphasalazine in rheumatoid arthritis: pointers to a gut-mediated immune effect.
    Sheldon PJ; Webb C; Grindulis KA
    Br J Rheumatol; 1987 Aug; 26(4):318-9. PubMed ID: 2886178
    [No Abstract]   [Full Text] [Related]  

  • 2. Which component of sulphasalazine is active in rheumatoid arthritis?
    Pullar T; Hunter JA; Capell HA
    Br Med J (Clin Res Ed); 1985 May; 290(6481):1535-8. PubMed ID: 2860942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which component of sulphasalazine is active in rheumatoid arthritis?
    Situnayake RD; McConkey B
    Br Med J (Clin Res Ed); 1985 Jul; 291(6488):138. PubMed ID: 2861878
    [No Abstract]   [Full Text] [Related]  

  • 4. Sulphasalazine in the treatment of rheumatoid arthritis.
    Box SA; Pullar T
    Br J Rheumatol; 1997 Mar; 36(3):382-6. PubMed ID: 9133974
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-Aminosalicylic acid or sulphapyridine. Which is the active moiety of sulphasalazine in rheumatoid arthritis?
    Taggart AJ; Neumann VC; Hill J; Astbury C; Le Gallez P; Dixon JS
    Drugs; 1986; 32 Suppl 1():27-34. PubMed ID: 2877851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulfasalazine treatment and lymphocyte function in patients with rheumatoid arthritis.
    Symmons DP; Salmon M; Farr M; Bacon PA
    J Rheumatol; 1988 Apr; 15(4):575-9. PubMed ID: 2899645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects of sulphasalazine, 5-aminosalicylic acid and sulphapyridine on the humoral response to antigen in vivo.
    Sheldon P; Pell P
    Adv Exp Med Biol; 1995; 371B():905-8. PubMed ID: 7502923
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of sulphasalazine on neutrophil superoxide generation in rheumatoid arthritis.
    Bradley SM; le Gallez P; Throughton PR; Gooi HC; Astbury C; Bird HA
    Br J Rheumatol; 1997 May; 36(5):530-4. PubMed ID: 9189053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro immunomodulatory effects of sulfasalazine and its metabolites.
    Comer SS; Jasin HE
    J Rheumatol; 1988 Apr; 15(4):580-6. PubMed ID: 2899646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment with sulfasalazine or sulfapyridine, but not 5-aminosalicyclic acid, inhibits basic fibroblast growth factor-induced endothelial cell chemotaxis.
    Volin MV; Harlow LA; Woods JM; Campbell PL; Amin MA; Tokuhira M; Koch AE
    Arthritis Rheum; 1999 Sep; 42(9):1927-35. PubMed ID: 10513809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulphasalazine therapy in rheumatoid arthritis: qualitative changes in lymphocytes and correlation with clinical response.
    Samanta A; Webb C; Grindulis KA; Fleming J; Sheldon PJ
    Br J Rheumatol; 1992 Apr; 31(4):259-63. PubMed ID: 1348199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sulfasalazine on B cell hyperactivity in patients with rheumatoid arthritis.
    Imai F; Suzuki T; Ishibashi T; Tanaka M; Akiyama Y; Dohi Y
    J Rheumatol; 1994 Apr; 21(4):612-5. PubMed ID: 7913501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B27 related arthritis, sulphasalazine and rheumatoid arthritis.
    Sheldon P
    Br J Rheumatol; 1987 Oct; 26(5):321-4. PubMed ID: 2889499
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of sulfasalazine on B cells.
    Imai F; Suzuki T; Ishibashi T; Dohi Y
    Clin Exp Rheumatol; 1991; 9(3):259-64. PubMed ID: 1678997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
    Bird HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the beneficial effect of sulfasalazine due to inhibition of synovial neovascularization?
    Madhok R; Wijelath E; Smith J; Watson J; Sturrock RD; Capell HA
    J Rheumatol; 1991 Feb; 18(2):199-202. PubMed ID: 1708829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulphasalazine and its metabolites on mitogen induced transformation of lymphocytes--clues to its clinical action?
    Sheldon P; Webb C; Grindulis KA
    Br J Rheumatol; 1988 Oct; 27(5):344-9. PubMed ID: 2902897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulphasalazine: mechanism of action in rheumatoid arthritis.
    Smedegård G; Björk J
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the effect of oral sulphasalazine, sulphapyridine and 5-amino-salicylic acid on the in vivo antibody response to oral and systemic antigen.
    Sheldon P; Pell P
    Br J Clin Pharmacol; 1993 Mar; 35(3):261-4. PubMed ID: 8097101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.